How should insulin aspart (rapid‑acting) and insulin degludec (ultra‑long‑acting) be properly administered in an insulin‑naïve adult patient?

Proper Administration of Insulin Aspart and Insulin Degludec in an Insulin-Naïve Patient

For an insulin-naïve adult patient with type 2 diabetes, start insulin degludec (basal insulin) at 10 units once daily OR 0.1–0.2 units/kg/day, administered at the same time each day, and add insulin aspart (rapid-acting prandial insulin) at 4 units before the largest meal only if A1C remains above goal after basal insulin optimization. 1

Initial Basal Insulin (Degludec) Administration

Starting Dose and Timing

• Begin with 10 units once daily OR 0.1–0.2 units/kg/day of insulin degludec 1
• Administer at the same time each day – degludec's ultra-long duration of action (>30 hours) allows flexibility, but consistency is preferred initially 2
• Inject subcutaneously in the abdomen, thighs, buttocks, or upper arms 1
• Rotate injection sites systematically – inject at least 1 cm from previous injection sites, changing body zones weekly to prevent lipodystrophy 1

Titration Protocol

• Set a fasting plasma glucose (FPG) target of 90–150 mg/dL (5.0–8.3 mmol/L) 1
• Increase dose by 2 units every 3 days until FPG goal is reached without hypoglycemia 1
• If hypoglycemia occurs (glucose <70 mg/dL): determine the cause, and if no clear reason exists, reduce dose by 10–20% 1
• Assess for overbasalization at every visit: look for basal doses >0.5 units/kg/day, elevated bedtime-to-morning glucose differential, hypoglycemia, or high glucose variability 1

Adding Prandial Insulin (Aspart) When Needed

Indications for Adding Aspart

• Add insulin aspart only if A1C remains above goal after basal insulin has been optimized 1
• Consider adding a GLP-1 receptor agonist first before prandial insulin if the patient is not already on one, as this combination reduces hypoglycemia and weight gain 1

Starting Prandial Insulin

• Begin with 4 units of insulin aspart OR 10% of the basal insulin dose 1
• Administer before the largest meal or the meal with the greatest postprandial glucose excursion 1
• If A1C <8% when adding prandial insulin, reduce basal dose by 4 units or 10% to prevent hypoglycemia 1
• Inject 0–15 minutes before eating – aspart is a rapid-acting insulin with onset in 10–20 minutes 1

Titration of Prandial Insulin

• Increase aspart dose by 1–2 units or 10–15% twice weekly based on pre-meal and 2-hour postprandial glucose readings 1
• For hypoglycemia: determine cause; if no clear reason, reduce the corresponding dose by 10–20% 1

Practical Administration Techniques

Injection Site Management

• Use abdomen, thighs, buttocks, or upper arms – these sites have sufficient subcutaneous fat 1
• Avoid the arm for self-injection unless assistance is available to ensure proper 90-degree angle 1
• Rotate systematically within and between zones – use one body zone quadrant/half per week 1
• Inspect skin before injection – ensure it is clean, intact, and free of lipodystrophy 1
• If applying two injections simultaneously (e.g., basal and prandial), use separate injection sites 1

Storage and Handling

• Store unopened vials/pens refrigerated at 2–8°C (36–46°F) without freezing 1
• Once opened, store at room temperature (15–30°C or 59–86°F) away from direct sunlight for up to 28 days 1
• Allow insulin to reach room temperature before injecting (30–60 minutes out of refrigerator) – cold insulin increases pain and lipodystrophy risk 1
• Inspect insulin before each use – degludec and aspart should both be clear; discard if cloudy, clumped, or discolored 1

Mixing Considerations

• Do NOT mix insulin degludec with any other insulin – its unique formulation requires separate administration 1
• Insulin aspart can be mixed with NPH if needed, but should be drawn up first and injected within 15 minutes 1

Special Considerations and Common Pitfalls

Hypoglycemia Prevention

• Lower starting doses (0.1 units/kg) are preferred for patients at higher risk: those >65 years old, with renal failure (eGFR <60 mL/min/1.73m²), or with poor oral intake 1
• For patients on home insulin ≥0.6 units/kg/day, reduce total daily dose by 20% when initiating in-hospital or during illness 1
• Monitor for nocturnal hypoglycemia – degludec has lower nocturnal hypoglycemia rates than other basal insulins, but aspart increases diurnal hypoglycemia risk 3, 4

Timing Flexibility

• Degludec offers unique timing flexibility – once stabilized, it can be administered at varying times (even alternating 8–40 hour intervals) without loss of efficacy 2
• However, maintain consistent timing initially until glucose patterns are established 2

When to Intensify Further

• If A1C remains above goal on basal-plus-one regimen, add aspart before additional meals (stepwise to 2, then 3 injections daily) 1
• Alternatively, consider switching to a fixed-ratio combination (IDegLira or iGlarLixi) if the patient is on or needs a GLP-1 receptor agonist 1

Disposal and Safety

• Use insulin syringes/pens and needles only once per manufacturer recommendations 1
• Dispose of sharps in puncture-resistant containers according to local regulations 1
• Never recap, bend, or break needles to avoid needle-stick injuries 1